Aardvark Therapeutics (AARD) files $400M mixed shelf

Aardvark Therapeutics (NASDAQ: AARD) has filed $400,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Rights

Units

Depositary Shares

You May Also Be Interested In

• Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL);
• Federated Hermes partners with Conduit on tokenized fund in APAC
• Pizza Hut CEO Aaron Powell resigns